Ardent Health Partners Inc
NYSE:ARDT

Watchlist Manager
Ardent Health Partners Inc Logo
Ardent Health Partners Inc
NYSE:ARDT
Watchlist
Price: 10.71 USD 0.47% Market Closed
Market Cap: 1.5B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ARDT stock under the Base Case scenario is 36.61 USD. Compared to the current market price of 10.71 USD, Ardent Health Partners Inc is Undervalued by 71%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ARDT Relative Value
Base Case
36.61 USD
Undervaluation 71%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.3
P/S
P/S
Price to Sales
0.3
vs History
50
vs Industry
83
Median 3Y
0.3
Median 5Y
0.3
Industry
2.3
Forward
0.2
More Details
6.8
P/E
P/E
Price to Earnings
6.8
vs History
50
vs Industry
42
Median 3Y
7.7
Median 5Y
7.7
Industry
22.1
Forward
5.5
More Details
5
P/OCF
P/OCF
Price to OCF
5
vs History
50
vs Industry
46
Median 3Y
5.7
Median 5Y
5.7
Industry
14.3
More Details
103.6
P/FCFE
P/FCFE
Price to FCFE
103.6
vs History
35
vs Industry
5
Median 3Y
93.1
Median 5Y
93.1
Industry
20.2
More Details
1.3
P/B
P/B
Price to Book Value
1.3
vs History
85
vs Industry
48
Median 3Y
1.9
Median 5Y
1.9
Industry
2.2
More Details
0.4
EV/S
EV/S
Enterprise Value to Sales
0.4
vs History
50
vs Industry
82
Median 3Y
0.4
Median 5Y
0.4
Industry
2.5
Forward
0.3
More Details
0.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.6
vs History
50
vs Industry
84
Median 3Y
0.7
Median 5Y
0.7
Industry
5.1
More Details
3.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
3.9
vs History
50
vs Industry
49
Median 3Y
4.3
Median 5Y
4.3
Industry
11.7
Forward
3.4
More Details
5.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
5.4
vs History
50
vs Industry
45
Median 3Y
5.9
Median 5Y
5.9
Industry
16.1
Forward
4.1
More Details
7
EV/OCF
EV/OCF
Enterprise Value to OCF
7
vs History
50
vs Industry
42
Median 3Y
7.6
Median 5Y
7.6
Industry
14.4
More Details
18
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
18
vs History
50
vs Industry
23
Median 3Y
19.6
Median 5Y
19.6
Industry
18.1
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
85
vs Industry
73
Median 3Y
0.7
Median 5Y
0.7
Industry
1.9
More Details

Multiples Across Competitors

ARDT Competitors Multiples
Ardent Health Partners Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Ardent Health Partners Inc
NYSE:ARDT
1.5B USD 0.3 6.8 3.9 5.4
US
HCA Healthcare Inc
NYSE:HCA
82.9B USD 1.1 13.9 8.4 11
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 7.7 41.6 34 41.5
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
19.7B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
18.3B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
123.8B CNY 5.7 33.4 26.6 26.6
US
Tenet Healthcare Corp
NYSE:THC
14.5B USD 0.7 10 5.9 7.3
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.2T INR 17.4 113.6 69.9 83.6
MY
IHH Healthcare Bhd
KLSE:IHH
58.2B MYR 2.4 24.2 11.6 16.9
BR
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
72.1B BRL 1.4 17.7 7 8.4
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1.1T INR 4.9 74 36.7 49

See Also

Summary
ARDT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARDT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARDT stock valuation using valuation multiples.
Wall Street Estimates
ARDT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARDT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 271,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.